Adial Pharmaceuticals, Inc. WT EXP 073123
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Adial Pharmaceuticals, Inc. WT EXP 073123 generated cash of -$6,806,809, which is more than the previous year. Cash used in financing activities reached the amount of $4,132,097 last year. Net change in cash is therefore -$1,174,712.
Cash Flow
| 2015 | -465.22K | 0 | 0 |
|---|---|---|---|
| 2016 | -274.38K | 0 | 200K |
| 2017 | -494.86K | 35.11K | 390K |
| 2018 | -2.49M | 0 | 6.34M |
| 2019 | -6.33M | 0 | 9.24M |
| 2020 | -7.63M | -350K | 5.60M |
| 2021 | -11.94M | -34.01K | 13.64M |
| 2022 | -11.18M | 0 | 9.12M |
| 2023 | -6.80M | 1.5M | 4.13M |
ADILW Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 4.00M | 6.06M | 4.40M | 6.77M | 3.86M | 18.24K | 87.99K | 162.37K | 627.59K |
Operating activities | |||||||||
Net income | -7.00M | -12.73M | -19.42M | -10.89M | -8.59M | -11.63M | -1.13M | -420.2K | -817.99K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 564 | 60.50K | 55.10K | 564 | 565 | 563 | 565 | 565 | 565 |
Stock-based compensation expense | 1.74M | 3.37M | 4.24M | 2.01M | 1.60M | 0 | 205.39K | 153.56K | 250.82K |
| Deferred income tax benefit | 1.74M | 3.37M | 4.24M | 2.01M | 1.60M | 0 | 205.39K | 153.56K | 250.82K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | -367 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -183.47K | 108.34K | -353.77K | 458.53K | 90.53K | -34.80K | 324.81K | 0 | 15.84K |
Cash generated by operating activities | -6.80M | -11.18M | -11.94M | -7.63M | -6.33M | -2.49M | -494.86K | -274.38K | -465.22K |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -64.60K | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 30.58K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 1.5M | 0 | -34.01K | -350K | 0 | 0 | 35.11K | 0 | 0 |
Financing activities | |||||||||
Common Stock Issued | 4.13M | 9.12M | 11.75M | 5.60M | 8.19M | 6.26M | 40K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -1.66K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -760K | 350K | 0 | 0 |
Cash used in financing activities | 4.13M | 9.12M | 13.64M | 5.60M | 9.24M | 6.34M | 390K | 200K | 0 |
Net Change In Cash | -1.17M | -2.06M | 1.66M | -2.37M | 2.90M | 3.85M | -69.74K | -74.38K | -465.22K |
Cash at end of period | 2.82M | 4.00M | 6.06M | 4.40M | 6.77M | 3.86M | 18.24K | 87.99K | 162.37K |
| Data source | Data source | Data source | Data source | Data source | Data source |